HLA-B27 Antibodies

Santa Cruz Biotechnology features a diverse variety of HLA-B27 monoclonal antibodies for immunology and related fields research. HLA-B27 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-B27 is a major histocompatibility complex (MHC) class I molecule that plays a key role in the immune response by presenting peptides to CD8+ T cells. Research has shown strong associations between HLA-B27 and autoimmune diseases, particularly ankylosing spondylitis and other spondyloarthropathies. Understanding HLA-B27 function and expression patterns helps reveal disease mechanisms and improve patient stratification. Investigating HLA-B27 molecular interactions provides valuable insights into disease pathogenesis and supports the development of targeted therapies. Researchers can leverage specific detection methods to examine HLA-B27 expression in various tissue types and experimental conditions. Advanced visualization techniques enable detailed analysis of HLA-B27 localization and trafficking within cells. Santa Cruz Biotechnology monoclonal antibodies for HLA-B27 support researchers worldwide in advancing our understanding of immune system regulation and disease processes.